Patient-related reported outcomes (PROs) from TALAPRO-2: the PROs and cons

Editorial

Open access

Edoardo Francini

CHINESE CLINICAL ONCOLOGY, Vol.14(5), pp.62-62

10/31/2025

DOI: 10.21037/cco-25-62

PMID: 41116982

Files and links (1)

url

https://doi.org/10.21037/cco-25-62View

Published (Version of record) Open Access

Editorial commentary

Oncology

Life Sciences & Biomedicine

Science & Technology

Title: Subtitle: Patient-related reported outcomes (PROs) from TALAPRO-2: the PROs and cons
Creators: Edoardo Francini - University of Florence
Resource Type: Editorial
Publication Details: CHINESE CLINICAL ONCOLOGY, Vol.14(5), pp.62-62
DOI: 10.21037/cco-25-62
PMID: 41116982
NLM abbreviation: Chin Clin Oncol
ISSN: 2304-3865
eISSN: 2304-3873
Publisher: AME PUBLISHING COMPANY
Number of pages: 4
Language: English
Date published: 10/31/2025
Academic Unit: Internal Medicine
Record Identifier: 9985221143802771

1 Record Views